3-(2,2,2-trimethylhydrazine)propionate has been researched along with Body Weight in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Pugovics, O; Skapare, E; Svalbe, B; Vilskersts, R | 1 |
Cirule, H; Dambrova, M; Liepinsh, E; Makrecka, M; Skapare, E; Svalbe, B | 1 |
Hagino, H; Kameyama, Y; Nagira, K; Teshima, R | 1 |
Kalvinsh, I; Kloner, RA; Sesti, C; Simkhovich, BZ | 1 |
Beauseigneur, F; Bezard, J; Boichot, J; Clouet, P; Demarquoy, J; Gresti, J; Niot, I; Rochette, L; Tsoko, M | 1 |
Arutiunian, AV; Burmistrov, SO; Konstantinova, NN; Krivtsova, EI; Oparina, TI; Pavlova, NG; Ponomarenko, IuP; Prokopenko, VM | 1 |
Asaka, N; Hayashi, Y; Kanno, T; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M | 1 |
Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K | 1 |
8 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Body Weight
Article | Year |
---|---|
Effects of long-term mildronate treatment on cardiac and liver functions in rats.
Topics: Animals; Betaine; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Glucose; Heart; Hemodynamics; Lipids; Liver; Liver Glycogen; Male; Methylhydrazines; Myocardium; Rats; Rats, Wistar; Time Factors; Toxicity Tests, Chronic | 2009 |
Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats.
Topics: Animals; Blood Glucose; Body Weight; Cell Nucleus; Drug Combinations; Eating; Gene Expression Regulation; Hypoglycemic Agents; Insulin; Lactic Acid; Lipid Metabolism; Male; Metformin; Methylhydrazines; Myocardium; Obesity; PPAR alpha; PPAR gamma; Rats; Rats, Zucker; RNA, Messenger | 2011 |
Effects of minodronate on cortical bone response to mechanical loading in rats.
Topics: Animals; Body Weight; Bone and Bones; Dose-Response Relationship, Drug; Female; Methylhydrazines; Rats; Rats, Wistar; Stress, Physiological | 2013 |
Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics.
Topics: Angina Pectoris; Animals; Blood Pressure; Body Weight; Cardiovascular Agents; Fatty Acids; Female; Heart Rate; Methylhydrazines; Myocardial Infarction; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2006 |
Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor.
Topics: Animals; Body Weight; Carnitine; Fatty Acids; gamma-Butyrobetaine Dioxygenase; Liver; Male; Methylhydrazines; Mixed Function Oxygenases; Organ Size; Oxidation-Reduction; Rats; Rats, Wistar | 1995 |
[Mechanism of the mildronate effect on the development of rabbit embryos during placental insufficiency].
Topics: Animals; Antioxidants; Body Weight; Brain; Embryonic and Fetal Development; Female; Fetal Hypoxia; Methylhydrazines; Placenta; Placental Insufficiency; Pregnancy; Rabbits; Vasodilator Agents | 1998 |
Beneficial effects of MET-88 on left ventricular dysfunction and hypertrophy with volume overload in rats.
Topics: Animals; Body Weight; Cardiac Volume; Cardiomegaly; Cardiovascular Agents; Heart; Hemodynamics; Male; Methylhydrazines; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin; Ventricular Dysfunction, Left | 1999 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate | 2000 |